SCOTTISH MEDICINES CONSORTIUM (SMC) ENABLES ACCESS TO THE FIRST NEW TREATMENT IN 40 YEARS FOR RARE INHERITED BONE DISORDER IN CHILDREN
Kyowa Kirin International today announced that the SMC has enabled access to Crysvita® (burosumab) in the NHS in Scotland to treat X-linked hypophosphataemia (X... Read More...